Potent SIRT1 enzyme-stimulating and anti-glycation activities of polymethoxyflavonoids from Kaempferia parviflora

Natural Product Communications

Volumn 9, Issue 9, 2014, Pages 1291-1294

  Nakata, Asami ^a   Koike, Yuka ^b   Matsui, Hirofumi ^c   Shimada, Tsutomu ^d   Aburada, Masaki ^d   Yang, Jinwei ^a  

^a Tokiwa Phytochemical Co   (Japan)

^b SHOWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d MUSASHINO UNIVERSITY   (Japan)

Author keywords

Advanced glycation end products; Black turmeric; Kaempferia parviflora; Polymethoxyflavonoids; SIRT1

Indexed keywords

3,5,7 TRIMETHOXYFLAVONE; 3,5,7,3',4' PENTAMETHOXYFLAVONE; 3,5,7,4' TETRAMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; 5,7,4' TRIMETHOXYFLAVONE; AMINOGUANIDINE; FLAVONOID; NOBILETIN; PLANT EXTRACT; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG; SIRT1 PROTEIN, HUMAN;

ANTI GLYCATION ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; ENZYME ACTIVATION; IC50; IN VITRO STUDY; KAEMPFERIA PARVIFLORA; RHIZOME; STRUCTURE ACTIVITY RELATION; ZINGIBERACEAE; CHEMISTRY; DRUG EFFECTS; GLYCOSYLATION; HUMAN; KINETICS; METABOLISM;

ENZYME ACTIVATION; FLAVONOIDS; GLYCOSYLATION; HUMANS; KINETICS; PLANT EXTRACTS; SIRTUIN 1; ZINGIBERACEAE;

EID: 84907533283     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1400900918     Document Type: Article

References (25)

1. Sawasdee P, Sabphon C, Sitthiwongwanit D, Kokpol U. (2009) Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora. Phytotherapy Research, 23, 1792-1794.
2. Wattanapitayakul SK, Suwatronnakorn M, Chularojmontri L, Herunsalee A, Niumsakul S, Charuchongkolwongse S, Chansuvanich N. (2007) Kaempferia parviflora ethanolic extract promoted nitric oxide production in human umbilical vein endothelial cells. Journal of Ethnopharmacology, 110, 559-562.
3. Sae-wong C, Tansakul P, Tewtrakul S. (2009) Anti-inflammatory mechanism of Kaempferia parviflora in murine macrophage cells (RAW 264.7) and in experimental animals. Journal of Ethnopharmacology, 124, 576-580.
4. Wattanapitayakul SK, Chularojmontri L, Herunsalee A, Charuchongkolwongse S, Chansuvanich N. (2008) Vasorelaxation and antispasmodic effects of Kaempferia parviflora ethanolic extract in isolated rat organ studies. Fitoterapia, 79, 214-216.
5. Tewtrakul S, Subhadhirasakul S. (2007) Anti-allergic activity of some selected plants in the Zingiberaceae family. Journal of Ethnopharmacology, 109, 535-538.
6. Akase T, Shimada T, Terabayashi S, Ikeya Y, Sanada H, Aburada M. (2011) Antiobesity effects of Kaempferia parviflora in spontaneously obese type II diabetic mice. Journal of Natural Medicines, 65, 73-80.
7. Shimada T, Horikawa T, Ikeya Y, Matsuo H, Kinoshita K, Taguchi T, Ichinose K, Takahashi K, Aburada M. (2011) Preventive effect of Kaempferia parviflora ethyl acetate extract and its major components polymethoxyflavonoid on metabolic diseases. Fitoterapia, 82, 1272-1278.
8. Rujjanawate C, Kanjanapothi D, Amornlerdpison D, Pojanagaroon S. (2005) Anti-gastric ulcer effect of Kaempferia parviflora. Journal of Ethnopharmacology, 102, 120-122.
9. Horikawa T, Shimada T, Okabe Y, Kinoshita K, Koyama K, Miyamoto K, Ichinose K, Takahashi K, Aburada M. (2012) Polymethoxyflavonoids from Kaempferia parviflora induce adipogenesis on 3T3-L1 preadipocytes by regulating transcription factors at an early stage of differentiation. Biological & Pharmaceutical Bulletin, 35, 686-692.
10. Feige JN, Auwerx J. (2008) Transcriptional targets of sirtuins in the coordination of mammalian physiology. Current Opinion in Cell Biology, 20, 303-309.
11. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang L, Scherer B, Sinclair DA. (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 425, 191-196.
12. Cerami A, Vlassara H, Brownlee M. (1987) Glucose and aging. Scientific American, 256, 90-96.
13. Bastaa G, Schmidtb AM, Caterinaa RD. (2004) Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovascular Research, 63, 582-592.
14. Yuan Q, Zhou QY, Liu D, Yu L, Zhan L, Li XJ, Peng HY, Zhang XL, Yuan XC. (2014) Advanced glycation end-products impair Na+/K+-ATPase activity in diabetic cardiomyopathy: role of the AMPK/SIRT1 pathway. Clinical Experimental Pharmacology and Physiology, 41, 127-133.
15. Sutthanut K, Sripanidkulchai B, Yenjai C, Jay M. (2007) Simultaneous identification and quantitation of 11 flavonoid constituents in Kaempferia parviflora by gas chromatography. Journal of Chromatography A, 1143, 227-233.
16. Hori M, Yagi M, Nomoto K, Ichijo R, Shimoda A, Kitano T, Yonei Y. (2012) Experimental models for advanced glycation end product formation using albumin, collagen, elastin, keratin and proteoglycan. Anti-Aging Medicine, 9, 125-134.
17. Jariyapamornkoon N, Yibchok-anun S, Adisakwattana S. (2013) Inhibition of advanced glycation end products by red grape skin extract and its antioxidant activity. BMC Complementary and Alternative Medicine, 13, 171-179.
18. Murakami A, Nakamura Y, Ohto Y, Yano M, Koshiba T, Koshimizu K, Tokuda H, Nishino H, Ohigashi H. (2000) Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Biofactors, 12, 187-192.
19. Borra MT, Smith BC, Denu JM. (2005) Mechanism of human SIRT1 activation by resveratrol. Journal of Biological Chemistry, 280, 17187-17195.
20. Milne JC, Lambert PD, Schenk S, Carney DP, Smith JJ, Gagne DJ, Jin L, Boss O, Perni RB, Vu CB, Bemis JE, Xie R, Disch JS, Ng PY, Nunes JJ, Lynch AV, Yang H, Galonek H, Israelian K, Choy W, Iffland A, Lavu S, Medvedik O, Sinclair DA, Olefsky JM, Jirousek MR, Elliott PJ, Westphal CH. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450, 712-716.
21. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K. (2010). SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. Journal of Biological Chemistry, 285, 8340-8351.
22. Liang F, Kume S, Koya D. (2009) SIRT1 and insulin resistance. Nature Reviews Endocrinology, 5, 367-373.
23. Ohta H. (2007) The mechanism of vascular senescence regulated by longevity gene, Sirt1. Nippon Ronen Igakkai Zasshi, 44, 194-197.
24. Rodgers JT, Puigserver P. (2007) Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin. Proceedings of National Academy of Sciences USA, 104, 12861-12866.
25. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. (2004) Modulation of NFκB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO Journal, 23, 2369-2380.